A recently approved contraceptive vaginal ring—the first that can be used for an entire year—is a highly effective birth control method, according to clinical trial data that will be presented Tuesday at ENDO 2019, the Endocrine Society’s annual meeting in New Orleans, La.
Researchers are investigating if daily mindful meditation through an app could decrease anxiety in antepartum patients, who are hospitalized due to pregnancy complications, in a new trial at UTHealth.
White women with polycystic ovary syndrome (PCOS) have significantly higher anxiety symptoms compared to black women with the condition, a new study suggests. These symptoms may be related to obesity, according to the research to be presented Monday, March 25 at ENDO 2019, the annual meeting of the Endocrine Society, in New Orleans, La.
Endocrine disruptors, hormone-altering chemicals that are widespread in our environment, can shape the brain through four generations, altering offspring’s maternal behavior, sexual development and reproduction, according to a new animal study. The results of this study will be presented Monday at the Endocrine Society’s annual meeting in New Orleans, La.
Changing when you eat rather than what you eat may prove to be a dietary intervention against breast cancer, suggests a new mouse study to be presented Saturday at ENDO 2019, the Endocrine Society’s annual meeting in New Orleans, La.
Walking downhill after eating can reduce bone resorption, the process in which old bone is broken down and removed from the body, in postmenopausal women with diabetes, according to research to be presented Sunday, March 24 at ENDO 2019, the annual meeting of the Endocrine Society, in New Orleans, La. Walking uphill does not have the same benefit, the study found.
The benefits of treating osteoporosis in postmenopausal women outweigh the perceived risks, according to a Clinical Practice Guideline issued today by the Endocrine Society. The Society introduced the guideline during a news conference on Monday at ENDO 2019, its annual meeting in New Orleans, La.
Franci van den Berg and Nina Pye live 13,500 kilometers apart: one at the southern tip of Africa, the other in London. Both young women have spent years grappling with psychogenic non-epileptic seizures (PNES) and their physical, psychological, emotional and social consequences.
As FDA approval of the first postpartum depression drug hits the news, study looks at how infant fussiness and a baby's level of prematurity may influence the severity of maternal depressive symptoms.
Georgetown researchers have launched a series of mobile games in Nepal to reach young people with information about fertility awareness and family planning.
Exposure to the widely used chemical bisphenol A (BPA) during pregnancy, even at levels lower than the regulated “safe” human exposure level, can lead to changes in circadian rhythms, according to a mice study to be presented Monday at ENDO 2019, the Endocrine Society’s annual meeting in New Orleans, La. The researchers report these changes may be a contributing factor in hyperactivity seen in BPA-exposed mice.
The ketogenic diet recently has been touted for weight loss and improving blood sugar control, but a new study finds that females fail to show these metabolic benefits on this high-fat, very low-carbohydrate diet. Results of the animal study will be presented Sunday at the Endocrine Society’s annual meeting in New Orleans, La.
Exposure to dim light at night, which is common in today’s lifestyle, may contribute to the spread of breast cancer to the bones, researchers have shown for the first time in an animal study. Results of the study will be presented Saturday at ENDO 2019, the Endocrine Society’s annual meeting in New Orleans, La.
In recent years, women who start taking bisphosphonates (BPs) to treat osteoporosis and prevent fracture have trended from younger to older and from having osteopenia to having osteoporosis, researchers report. The results of the study will be presented on Saturday at ENDO 2019, the Endocrine Society’s annual meeting in New Orleans, La.
Obesity may play a role in reproductive problems in women with type 1 diabetes, according to a new study to be presented Saturday, March 23 at ENDO 2019, the Endocrine Society’s annual meeting in New Orleans, La.
Young women are more likely to experience sleep disruption in the days leading up to their menstrual period, according to a new study that will be presented Saturday at ENDO 2019, the annual meeting of the Endocrine Society, in New Orleans, La.
Treating women who have thyroid antibodies, but normal thyroid function, with a medicine called Levothyroxine does not make them more likely to deliver a live baby, new research from the United Kingdom suggests. The research will be presented Saturday, March 23 at ENDO 2019, the Endocrine Society’s annual meeting in New Orleans, La., and published in The New England Journal of Medicine.
In what is believed to be a first-of-its-kind systematic look at pregnancy frequency and outcomes among imprisoned U.S. women, researchers from Johns Hopkins Medicine say almost 1,400 pregnant women were admitted to 22 U.S. state and all federal prisons in a recent year. They also found that most of the prison pregnancies — over 90 percent — ended in live births with no maternal deaths.
In this issue, find research on texting while driving laws, new data on Yoga use increasing, dairy milk in school breakfasts, pregnancy outcomes in prison and more.
In a first, researchers at the University of Pittsburgh School of Medicine and the Magee-Womens Research Institute have reported in a non-human primate model that immature testicular tissue can be cryopreserved, and later be used to restore fertility to the same animal.
Spontaneous preterm birth (sPTB), defined as birth before 37 weeks of gestation, and the related complications, are the largest contributors to infant death in the United States and worldwide, according to the World Health Organization. Researchers at the University of Maryland School of Medicine (UMSOM) have discovered that bacteria and innate immune factors in a woman’s birth canal and cervix may increase the risk of spontaneous preterm birth or provide protection against such births.
African-American women are nearly twice as likely to give birth prematurely as white women. Amelia Gavin, an associate professor in the University of Washington School of Social Work, connects preterm birth to racial discrimination via PTSD.
A single allergic reaction during pregnancy prompts sexual-development changes in the brains of offspring that last a lifetime, new research suggests. Female rats born to mothers exposed to an allergen during pregnancy acted more characteristically “male” – mounting other female rodents, for instance – and had brains and nervous systems that looked more like those seen in typical male animals.
Seven types of bacteria and certain immune factors in a woman’s vagina and cervix may be responsible for increasing the risk of spontaneous preterm birth (sPTB) or protect against it, according to a new study from the Perelman School of Medicine at the University of Pennsylvania and the University of Maryland School of Medicine. Results of the study provide groundbreaking information that the authors suggest could help physicians better predict preterm birth, especially for African-American women early in pregnancy.
Ludwig Cancer Research released today the full breadth of findings to be presented by Ludwig researchers at this year’s American Association for Cancer Research (AACR) Annual Meeting in Atlanta, Ga., March 29 – April 3, 2019. Research conducted by more than 75 Ludwig scientists will be shared in plenary sessions, major symposiums, education sessions, poster sessions and more.
FINDINGS The menopause transition, also known as perimenopause, is the time in a woman’s life when hormonal changes lead to irregular menstruation, hot flashes and other symptoms leading up to menopause, when menstruation stops altogether. The researchers found that women undergoing perimenopause lost lean body mass and more than doubled their fat mass.
ZULRESSO, developed by Sage Therapeutics, is the first and only treatment specifically indicated to treat postpartum depression in women. UNC School of Medicine’s Samantha Meltzer-Brody, MD, MPH, was the principal investigator for three clinical trials showing rapid-reduction in depressive symptoms, and says the approval marks a major step forward in women’s healthcare.
Vaginal laser is a non-hormonal treatment, which is reported to alleviate symptoms of dryness and pain in 95 percent of the women who undergo the laser treatment. However, because insurance does not cover the laser treatments, it is cost prohibitive for many women. To expand access to this innovative treatment, the Northwestern Medicine Center for Sexual Medicine and Menopause recently launched the Breast Cancer Vaginal Health Access (BRAVA) program, which will offer complimentary vaginal and vulvar laser treatments to eligible women living with a breast cancer diagnosis.
New research from Duke University, published in the March 2019 issue of JNCCN—Journal of the National Comprehensive Cancer Network, provides evidence that genomic recurrence score (RS) testing using the 21-gene assay is associated with lower costs for people with clinically high-risk breast cancer.
Results of a first-of-its-kind prospective study with a family planning app find it to be as effective as other modern methods for avoiding an unplanned pregnancy, according to Georgetown researchers.
African refugee women experience healthier pregnancies than women born in the United States, despite receiving less prenatal care, found a recent University at Buffalo study.
Ovarian cancer is often diagnosed too late for effective treatment. Israeli researchers are announcing the development of a liquid-biopsy-based diagnostic that may someday help catch the disease earlier.
A team of researchers at the George Washington University Cancer Center has identified the role the deubiquitinating enzyme USP15 as a potential biomarker in breast and pancreatic cancer treatments.
New insights into opioid alternatives to treat postpartum pain and medication to delay preterm labor, as well as breakthroughs in spina bifida surgery, were among the topics of research presented at the Society for Maternal-Fetal Medicine’s (SMFM) 39th Annual Pregnancy Meeting by faculty, students, and staff from UTHealth.
New research from the University of Delaware suggests pairing two forms of minimally invasive, light-triggered therapy may be a powerful new option in combatting a particularly aggressive form of breast cancer.
Researchers have found that a simple urine test can rapidly detect one of the world’s deadliest pregnancy-related conditions, which could have a major impact on global health.
Article recently published in Aesthetic Surgery Journal formalizes the treatment strategy for this diagnosis, offering clear guidelines for plastic and oncologic surgeons.
UNC School of Medicine scientists uncovered a possible reason why some breast cancers are so aggressive and difficult to treat: an enzyme called USP21 promotes proliferation of basal-like breast cancer and is upregulated in a significant percentage of patient tumors. It could become a drug target.
The 2019 Pittsburgh Women who Rock Award will be presented to Sharon L. Hillier, Ph.D., at the 3rd annual Women who Rock Benefit Concert Presented by UPMC Health Plan and UPMC Magee-Womens Hospital on Thursday, May 30, at Stage AE. Dr. Hillier is professor and vice chair of the department of obstetrics
University of Colorado Cancer Center study published in the journal Oncogene shows that while estrogen doesn’t directly affect triple-negative breast cancer cells, it can affect surrounding brain cells in ways that promote cancer cell migration and invasiveness.
The age a woman begins menstruation is associated with having high blood pressure later in her life, according to a team of researchers at the University of Georgia.
In the United States, approximately 12 percent of women have difficulty getting pregnant or staying pregnant. The first successful in vitro fertilization (IVF) cycle occurred in the United States in 1981. According to an analysis published in the March 2019 issue of the journal Fertility and Sterility, treatment options have continued to improve, in part, thanks to an annual report started 30 years ago by the Society for Assisted Reproductive Technology (SART). National IVF data collection and reporting for the past 30 years has provided fundamental industry-wide feedback, impacted health policy, improved safety, and ultimately improved the quality of care delivered to patients seeking fertility treatments.
Improvements are needed in VA's prescribing of hormone therapy for menopausal women veterans, concludes a study in the Journal for Healthcare Quality (JHQ), the peer-reviewed journal of the National Association for Healthcare Quality (NAHQ). The journal is published in the Lippincott portfolio by Wolters Kluwer.